Manufacturing: Page 6

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's Ahead for Biosimilars

    Denise Myshko Uncertainty lies ahead for the biosimilar market, as manufacturers await FDA guidance. Biosimilars could represent a multi-billion dollar market in the United States, although some questions remain, including the uptake by physicians and payers, pricing of biosimilars, and how the F...

    By Denise Myshko • Jan. 27, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Aaron BERG Essentialis Names CEO Essentialis, a pharmaceutical company focused on a novel medicine for the treatment of cardiovascular and metabolic disease, has promoted Aaron Berg to CEO, fro...

    By Carolyn Gretton • Jan. 27, 2012
  • test tube gene Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Cell and gene therapies

    How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    New commercial models paying dividends… Creating value — the goal for all companies — and how they achieve this goal are as different as the companies themselves. According to a recent report — Strength in the Storm: How Biopharmaceutical and Medical Technology Companies Can Create Value in a Cha...

    By Taren Grom • Jan. 26, 2012
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Forecasting Pharma's Future

    Forecasting Pharma’s Future Denise Myshko Given the volatility of today’s financial landscape, ­companies, more than ever, need a robust forecasting strategy that is clear, effective, and accurate. As companies seek to negotiate the volatility of emerging markets, the uncertainties of healthcare ...

    By Denise Myshko • Dec. 22, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Year of the Extreme Makeover

    Every sector in the industry is in a state of flux. In this special issue of PharmaVOICE, more than 160 thought leaders throughout the life-sciences industry discuss the changing market dynamics. According to PricewaterhouseCooper’s 14th Annual Global CEO Survey, which looks at the concerns expre...

    By Denise Myshko and Robin Robinsons • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Hola Mexico: Pharma Drawn to U.S. Neighbor

    By Kim Ribbin Growing health coverage, high medical standards, a ­motivated patient population, and huge geographic ­advantages make Mexico an appealing market for the ­pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast becom...

    By Kim Ribbink • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Dr. Tomas BOCANEGRA Pozen Appoints Development VP Pozen, a pharmaceutical company committed to developing medicines that transform lives, has named Tomas Bocanegra, M.D., executive VP of develo...

    By PharmaVoice Team • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Merhaba, Turkey: Opportunity Knocks

    As the largest pharmaceutical market in the Middle East and the fastest growing in the Mediterranean region, Turkey presents some exciting opportunities for the pharmaceutical market. Consumption of pharmaceuticals in Turkey totals around $8 billion, with 50% of these drugs being manufactured dom...

    By Kim Ribbink • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    DIA Preview

    New Tools, Services, and Products Designed to Improve Drug Development This special Drug Information Association section highlights the new and innovative products being offered by ­companies exhibiting at the upcoming 2011 DIA — 47th Annual Meeting in Chicago. (Note: briefs are listed alphabetic...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    CSR Gets a Makeover

    Corporate social responsibility (CSR) policies have been in place for decades at most companies, but the increased social awareness of today’s consumers has stepped up the visibility of such programs. The state of the world’s economy, the ever-evolving business environment, and an overall growth ...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HBA's 2011: Rising Stars

    These high-potential women, who ­represent all facets and ­disciplines of the ­life-sciences industry, are being ­recognized by their companies for: Significantly contributing to their organizations. Exemplifying true leadership and acting as a role model for others. Assisting those in subordinat...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: Honing the Edge

    “Almost 70% of companies ­participating in a recent study use a decentralized market ­research structure, and yet often don’t provide training for the skills that make cross-functional decentralized structures work." Market research, long a key component of success in most pharma operations and s...

    By Carolyn Gretton • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Ahn Nyeong: South Korea Emerges

    In just three years, South Korea has been reclassified from an emerging market to a developed market by IMS. This is based on South Korea’s GDP level, as well as a well-established and growing economy, rising income levels, better living conditions, and an improved healthcare system that has led ...

    By Kim Ribbink • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tapping Into the Power by ­Getting Personal

    More and more patients are using Facebook, YouTube, Twitter, and other social media outlets to discuss their health and treatments with peers and caregivers. Social media tools have become an effective way to expand reach, foster engagement, and increase access to credible, science-based health m...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Creating a Personalized Medicine Strategy

    Considered broadly, healthcare is personal. The goal of medical practitioners has always been to get the right drug to the right person at the right time at the right dose. But now industry experts say personalized medicine is at a tipping point as a multitude of factors converge, including advan...

    By Denise Myshko • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    John Gargiulo, Daiichi Sankyo’s new President and CEO, discusses the future opportunities for the company and the industry. Keeping the Patient Front and Center Last Word PV: What are your goals for Daiichi Sanyko? Gargiulo: The healthcare industry is currently experiencing unprecedented challeng...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Privyet! Russia: Growth and Opportunity

    With its promise of expansion, its population of around 140 million potential customers, and a pool of highly qualified staff, Russia has long been recognized as an important market for pharmaceutical companies. The pharma market in Russia has shown stable annual growth of 13% to 20% for several ...

    By Kim Ribbink • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Steve FRY Dr. Sue MAHONY Lilly Announces Leadership Shifts Lilly has promoted Steve Fry to senior VP of human resources and diversity. Mr. Fry was previously VP of human resources for two of Lilly’s business areas, biomedicines and emerging markets. Mr. Fry succeeds Sue Mahony...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Thought Leaders

    Ryan Abbate. President, Pacific ­Communications, a healthcare communications agency that ­offers strategic and tactical communications solutions. For more information, visit ­ ­pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized ­Medicine Coalition, which brings together the academ...

    By PharmaVoice Team • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Outsourcing: The Time is Right

    The recent world economic events have set the stage for the shape of the industry going forward. “As market conditions evolve, pharma companies are reducing their infrastructures and costs, resulting in a stronger reliance on vendors to meet trial objectives, timelines, and budgets," says Jim DeS...

    By PharmaVoice Team • March 7, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Through its recent acquisition of MedPage Today, a news organization serving healthcare professionals, Everyday Health has added a significant offering for healthcare professionals to its portfolio of consumer health information brands. MedPage provides healthcare professionals with peer-reviewed...

    By PharmaVoice Team • March 3, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Marketing: What Was Old Is New Again

    Patients, ROI, an evolving landscape, and so on have been on the minds of marketers for years; but today success will lie in new solutions and approaches to overcome these chronic issues through innovative technologies and adaptive strategies. Patients Take Center Stage Our experts tell us that t...

    By PharmaVoice Team • Nov. 10, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Accurate, Rapid Diagnosis Key to Developing ­Effective Infectious ­Disease Therapies MSLs Are Increasingly Important for Thought Leader Relationships Pharma Companies Increasing Outsource Manufacturing, ­Supply Chain IT ...

    By PharmaVoice Team • Sept. 28, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Lonnel COATS Eisai Names CEO for U.S. Subsidiary Eisai Inc., a U.S. subsidiary of Japan’s Eisai Co., has promoted Lonnel Coats to president and CEO, from president and chief operating officer. In addition, Mr. Coats has been appointed senior VP of Eisai Co.’s pharmaceuticals b...

    By PharmaVoice Team • Aug. 26, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's On The List by Section

    The Commanders & Chiefs Johanna Allston, Ph.D. – bioCapture Vicente Anido Jr., Ph.D. – ISTA Pharmaceuticals Mara Aspinall – On-Q-ity Glenn Bilawsky – i3 Jay Bolling – Roska Healthcare David Brennan – AstraZeneca Nick Colucci – Publicis Healthcare – Communications Group Lynnette Cooke – Kantar...

    By PharmaVoice Team • July 29, 2010